to enhance the health and quality of life for people throughout the world. For over 80 years, Novo Nordisk has combined drug discovery with technology to turn science into solutions for people with diabetes, people with hemophilia, children with growth hormone deficiency, and women experiencing the
symptoms of menopause. Our commitment to diabetes research is reflected in our variety of insulin products, other medical solutions, and the many exciting new treatment options in our pipeline. At Novo Nordisk, dedicated people with expertise in a variety of areas work together to develop pharmaceuticals, advanced delivery systems, and customized services.
